| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Olanzapine Impurity 25 |
ADP-BEJ-P1 |
52833-34-8 |
詳細(xì)
|
| Mirabegron impurity 003 |
米拉貝隆標(biāo)準(zhǔn)品003 |
1018983-85-1 |
詳細(xì)
|
| Vonoprazan Impurity 24 |
沃諾拉贊雜質(zhì)35 |
1883595-39-8 |
詳細(xì)
|
| Linezolid Impurity 42 |
2-氨基-3-氯丙烷-1-羥基 |
725676-93-7 |
詳細(xì)
|
| Olmesartan Impurity 13 |
奧美沙坦酯標(biāo)準(zhǔn)品013 |
138402-33-2 |
詳細(xì)
|
| Sodium 2-((2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl)acetate |
魯拉西酮標(biāo)準(zhǔn)品-NA |
136983-81-8 |
詳細(xì)
|
| 2-Chloro Vonoprazan |
文諾普蘭雜質(zhì) |
928325-68-2 |
詳細(xì)
|
| Linezolid Impurity 44 |
利奈唑胺雜質(zhì)10 |
183805-10-9 |
詳細(xì)
|
| 1-Methyl-4-sulfopyridinium Hydroxide Inner Salt |
文諾普蘭雜質(zhì) |
4416-69-7 |
詳細(xì)
|
| p-[N-(p-Fluorophenyl)formimidoyl]phenol |
4-{[(4-氟苯基)亞胺基]甲基}苯酚 |
3382-63-6 |
詳細(xì)
|
| Febuxostat Impurity 23 |
非布索坦雜質(zhì)39 |
2073891-59-3 |
詳細(xì)
|
| Tetrabutylammonium periodate |
四丁基高碘酸銨 |
65201-77-6 |
詳細(xì)
|
| Pendimethalin |
二甲戊靈 |
40487-42-1 |
詳細(xì)
|
| Cefazolin Impurity D |
頭孢唑啉雜質(zhì)D |
32510-61-5 |
詳細(xì)
|
| endo-BCN-PEG4-NHS ester |
ENDO BCN-PEG4-NHS ESTE |
1807501-86-5 |
詳細(xì)
|
| Celecoxib Related Compound B |
塞來(lái)昔布相關(guān)物質(zhì)B |
331943-04-5 |
詳細(xì)
|
| Resiquimod-[d5] |
Resiquimod D5 |
2252319-44-9 |
詳細(xì)
|
| Celecoxib Impurity A |
塞來(lái)昔布雜質(zhì)A |
170570-01-1 |
詳細(xì)
|
| Rifamycin S |
利福霉素S |
13553-79-2 |
詳細(xì)
|
| PF-04457845 |
N-噠嗪-3-基-4-(3-{[5-(三氟甲基)吡啶-2-基]醚}苯亞甲基丙酮)哌啶-1-羧酰胺 |
1020315-31-4 |
詳細(xì)
|
| Proteinase K |
蛋白酶K |
39450-01-6 |
詳細(xì)
|
| GYY-4137 Morpholine salt |
(4-甲氧基苯基)嗎啉基-二硫代膦酸與嗎啉的化合物 |
106740-09-4 |
詳細(xì)
|
| 6-Ethynyl-4,4-Dimethyl Thiochroman |
6-乙炔基-4,4-二甲基二氫苯并噻喃 |
118292-06-1 |
詳細(xì)
|
| N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide |
依度沙班雜質(zhì)RRR |
1255529-24-8 |
詳細(xì)
|
| Cefazolin EP Impurity G |
頭孢唑啉鈉雜質(zhì)G |
1172998-53-6 |
詳細(xì)
|
| Atorvastatin EP Impurity C |
阿托伐他汀鈣雜質(zhì)C |
693793-53-2 |
詳細(xì)
|
| 1-methylpyridin-1-ium-2-carboxamide iodide |
氯解磷定標(biāo)準(zhǔn)品3-I |
3861-69-6 |
詳細(xì)
|
| Terazosin EP Impurity E |
特拉唑嗪雜質(zhì)E |
102839-00-9 |
詳細(xì)
|
| 6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine hydrochloride |
特拉唑嗪雜質(zhì) |
70843-11-7 |
詳細(xì)
|
| Terazosin Related Compound A |
特拉唑嗪雜質(zhì) |
60548-08-5 |
詳細(xì)
|
| Dapoxetine Impurity 1 |
達(dá)泊西汀雜質(zhì) |
94305-25-6 |
詳細(xì)
|
| 3-(4-(3-hydroxy-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one |
達(dá)泊西汀雜質(zhì) |
2242008-36-0 |
詳細(xì)
|
| Nifuratel Impurity 6 |
3-氨基-5-[(甲基硫代)甲基]噁唑啉-2-酮 |
25517-72-0 |
詳細(xì)
|
| Nifuratel Impurity 4 |
硝呋太爾雜質(zhì)6 |
41359-15-3 |
詳細(xì)
|
| Terbutaline Impurity 6 hydrobromide |
特布他林雜質(zhì)8 |
28924-20-1 |
詳細(xì)
|
| Dapoxetine Impurity 2 |
達(dá)泊西汀雜質(zhì) |
2242008-37-1 |
詳細(xì)
|
| 1-(1-phenylethyl)imidazole |
依托咪酯標(biāo)準(zhǔn)品002 |
60197-34-4 |
詳細(xì)
|
| Dapoxetine Impurity 8 |
達(dá)泊西汀標(biāo)準(zhǔn)品004 |
2245197-07-1 |
詳細(xì)
|
| Palbociclib Impurity 10 |
帕布昔利布標(biāo)準(zhǔn)品012 |
2206135-30-8 |
詳細(xì)
|
| Palbociclib Impurity 2 |
帕博西尼雜質(zhì)G |
2204863-06-7 |
詳細(xì)
|
| Palbociclib Impurity 022 |
帕布昔利布雜質(zhì)E |
1779124-68-3 |
詳細(xì)
|
| Palbociclib Impurity 025 |
帕布昔利布標(biāo)準(zhǔn)品025 |
2174002-16-3 |
詳細(xì)
|
| Palbociclib Impurity F |
哌泊塞克雷布雜質(zhì)F |
1023594-49-1 |
詳細(xì)
|
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
帕布昔利布雜質(zhì) |
1941177-45-2 |
詳細(xì)
|
| Valdecoxib Impurity I |
3-[4-[4-(氨基磺?；?苯基]-5-甲基-3-異惡唑基]苯磺酰胺 |
1373038-59-5 |
詳細(xì)
|
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide |
帕瑞昔布鈉雜質(zhì)18 |
198471-06-6 |
詳細(xì)
|
| Valdecoxib Impurity B |
戊地昔布雜質(zhì)B |
1373038-60-8 |
詳細(xì)
|
| Palbociclib Impurity 030 |
Palbociclib-030 |
1211541-02-4 |
詳細(xì)
|
| Parecoxib Impurity 1 |
帕瑞昔布雜質(zhì)H |
1708094-99-8 |
詳細(xì)
|
| methyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate |
1-(2-氯乙酰基)-2-氧代吲哚啉-6-羧酸甲酯 |
1160293-25-3 |
詳細(xì)
|
| Palbociclib Impurity 029 |
哌柏西利雜質(zhì) |
1566082-34-5 |
詳細(xì)
|
| Lisinopril Impurity F |
賴諾普利雜質(zhì)F |
1132650-67-9 |
詳細(xì)
|
| Terazosin EP Impurity O |
特拉唑嗪EP雜質(zhì)O |
547730-06-3 |
詳細(xì)
|
| 1-Piperazinyl[(2R)-tetrahydro-2-furanyl]methanone |
鹽酸特拉唑嗪 |
412334-56-6 |
詳細(xì)
|
| Dapoxetine Impurity 2 hydrochloride |
達(dá)泊西汀雜質(zhì) |
2242008-38-2 |
詳細(xì)
|
| Terbutaline Impurity 22 |
特布他林雜質(zhì) |
1226543-90-3 |
詳細(xì)
|
| Esmolol Impurity 1 |
鹽酸艾司洛爾雜質(zhì)4 |
81147-94-6 |
詳細(xì)
|
| 3-(4-hydroxynaphthalen-1-yl)-1-phenylpropan-1-one |
達(dá)泊西汀雜質(zhì) |
126113-24-4 |
詳細(xì)
|
| Etomidate Impurity 1 |
依托咪酯雜質(zhì)1 |
844658-92-0 |
詳細(xì)
|
| 2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethan-1-one sulfate |
特布他林雜質(zhì) |
882066-15-1 |
詳細(xì)
|
| N-Tert-Butyldibenzylamine |
N,N-二芐基叔丁胺 |
30923-82-1 |
詳細(xì)
|
| Nifuratel Impurity 2 |
硝呋太爾雜質(zhì)4 |
1445990-09-9 |
詳細(xì)
|
| Dapoxetine Impurity 24 |
達(dá)泊西汀 |
908291-72-5 |
詳細(xì)
|
| tert-butyl 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carboxylate |
特拉唑嗪雜質(zhì) |
1260939-66-9 |
詳細(xì)
|
| Dabigatran Impurity 20 |
達(dá)比加群酯標(biāo)準(zhǔn)品007 |
1408238-39-0 |
詳細(xì)
|
| (R)-Terazosin |
鹽酸特拉唑嗪 |
109351-34-0 |
詳細(xì)
|
| Rosuvastatin Impurity 12 |
瑞舒伐他汀酸水解未完全產(chǎn)物 |
894787-93-0 |
詳細(xì)
|
| 1-methylpyridin-1-ium-2-carboxamide chloride |
氯解磷定標(biāo)準(zhǔn)品-CL |
21032-31-5 |
詳細(xì)
|
| Mirabegron impurity 002 |
米拉貝隆標(biāo)準(zhǔn)品002 |
81259-56-5 |
詳細(xì)
|
| Paroxetine Mesylate |
甲磺酸帕羅西汀 |
217797-14-3 |
詳細(xì)
|
| (2S)-Isopropyl 2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
索非布韋中間體 |
1256490-52-4 |
詳細(xì)
|
| Valdecoxib Impurity E |
戊地昔布雜質(zhì)E |
1373038-63-1 |
詳細(xì)
|
| Hydroxy Ivabradine |
羥基伊伐布雷定 |
1235547-07-5 |
詳細(xì)
|
| 3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole |
3-(4-甲基苯基)-5-三氟甲基吡唑 |
219986-64-8 |
詳細(xì)
|
| Parecoxib Impurity 24 |
帕瑞昔布雜質(zhì) |
198470-82-5 |
詳細(xì)
|
| Leucosceptoside A |
米團(tuán)花苷A |
83529-62-8 |
詳細(xì)
|
| Dacarbazine |
達(dá)卡巴嗪 |
4342-03-4 |
詳細(xì)
|
| 19-Hydroxy-10-deacetyl baccatin-III |
卡巴他賽雜質(zhì)30 |
154083-99-5 |
詳細(xì)
|
| Fomesafen |
氟磺胺草醚 |
72178-02-0 |
詳細(xì)
|
| Deoxyandrographolide |
去氧穿心蓮內(nèi)酯 |
79233-15-1 |
詳細(xì)
|
| Mogrol |
羅漢果醇 |
88930-15-8 |
詳細(xì)
|
| Nα,Nα-Bis-Fmoc-L-cystine bis(tert-butyl ester) |
(FMOC-CYS-OTBU)2 |
139592-37-3 |
詳細(xì)
|
| Ethyl 2-bromothiophene-3-carboxylate |
2-溴噻吩-3-羧酸乙酯 |
632325-50-9 |
詳細(xì)
|
| Posaconazole Diastereoisomer Related Compound 2 |
泊沙康唑非對(duì)映異構(gòu)體中間體2 |
166583-12-6 |
詳細(xì)
|
| 15(S)-Latanoprost |
15(S)-拉坦前列素 |
145773-22-4 |
詳細(xì)
|
| Pantoprazole EP Impurity E |
泮托拉唑雜質(zhì)E |
2115779-15-0 |
詳細(xì)
|
| Triethylene Glycol Mono(2-propynyl) Ether |
丙炔基-三聚乙二醇 |
208827-90-1 |
詳細(xì)
|
| Chrysin-7-O-glucoronide |
白楊素-7-0-Β-D-葡萄糖醛酸苷 |
35775-49-6 |
詳細(xì)
|
| Monodes(N-carboxymethyl)valine Daclatasvir |
達(dá)卡它韋雜質(zhì) |
1007884-60-7 |
詳細(xì)
|
| DOTA-NOC |
DOTA-NOC |
619300-53-7 |
詳細(xì)
|
| Ethyl 5-bromothieno[3,2-b]thiophene-6-carboxylate |
ETHYL 2-BROMOTHIENO[3,2-B]THIOPHENE-3-CARBOXYLATE |
2055722-78-4 |
詳細(xì)
|
| Dapagliflozin Impurity 3 |
達(dá)格列凈雜質(zhì) |
1807632-95-6 |
詳細(xì)
|
| Ingenol-5,20-acetonide |
巨大戟醇-5,20-縮丙酮 |
77573-43-4 |
詳細(xì)
|
| MCP110 |
化合物 T24437 |
521310-51-0 |
詳細(xì)
|
| (3R,5R)-Rosuvastatin Calcium |
瑞舒伐他汀鈣雜質(zhì)B02 |
1422515-55-6 |
詳細(xì)
|
| Heptakis(6-deoxy-6-thio)-beta-cyclodextrin |
全巰基-倍他-環(huán)糊精 |
160661-60-9 |
詳細(xì)
|
| Cy5-NHS ester |
CY5-NHS酯 |
146368-14-1 |
詳細(xì)
|
| Semax |
腦力肽 |
80714-61-0 |
詳細(xì)
|
| (3S,5R)-Rosuvastatin |
(3S,5R)-瑞舒伐他汀 |
1242184-42-4 |
詳細(xì)
|
| Polyadenosinic acid potassium salt |
多聚腺苷酸鉀鹽,POLY(A)鉀鹽 |
26763-19-9 |
詳細(xì)
|